Clinical Trial Update: Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial compared the antihypertensive combination valsartan/amlodipine (EXforge) with nifedipine in Chinese patients with hypertension, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• EXforge (valsartan/amlodipine) (valsartan and amlodipine)
• Nifedipine (nifedipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-06-01